Transfusion rates are increasing following total hip arthroplasty: Risk factors and outcomes

Journal of Arthroplasty

Volumn 28, Issue 8 SUPPL, 2013, Pages 34-37

  Browne, James A ^a   Adib, Farshad ^a   Brown, Thomas E ^a   Novicoff, Wendy M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Risk factors; Total hip arthroplasty; Transfusion

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ANEMIA; ARTICLE; BLOOD CONSERVATION; BLOOD TRANSFUSION; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; ELECTIVE SURGERY; FEMALE; GENDER; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDY; RISK FACTOR; SENESCENCE; SURGICAL PATIENT; TOTAL HIP PROSTHESIS; UNIVERSITY HOSPITAL;

RISK FACTORS; TOTAL HIP ARTHROPLASTY; TRANSFUSION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION; COHORT STUDIES; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MALE; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884164959     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2013.03.035     Document Type: Article

References (27)

1. Marik P.E., Corwin H.L. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008, 36(9):2667.
2. Engoren M., Mitchell E., Perring P., et al. The effect of erythrocyte blood transfusions on survival after surgery for hip fracture. J Trauma 2008, 65(6):1411.
3. Shander A., Hofmann A., Gombotz H., et al. Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol 2007, 21:271.
4. Carson J.L., Kuriyan M. What should trigger a transfusion?. Transfusion 2010, 50(10):2073.
5. Keating E.M., Meding J.B. Perioperative blood management practices in elective orthopaedic surgery. J Am Acad Orthop Surg 2002, 10(6):393.
6. Sukeik M., Alshryda S., Haddad F.S., et al. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 2011, 93(1):39.
7. Barr P.J., Donnelly M., Cardwell C., et al. Drivers of transfusion decision making and quality of the evidence in orthopedic surgery: a systematic review of the literature. Transfus Med Rev 2011, 25(4):304.e6. [Epub 2011 Jun 2].
8. Feagan B.G., Wong C.J., Lau C.Y., et al. Transfusion practice in elective orthopaedic surgery. Transfus Med 2001, 11(2):87.
9. Noticewala M.S., Nyce J.D., Wang W., et al. Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplasty 2012, 27(6):961.
10. Walsh T.S., Palmer J., Watson D., et al. Multicentre cohort study of red blood cell use for revision hip arthroplasty and factors associated with greater risk of allogeneic blood transfusion. Br J Anaesth 2012, 108(1):63. [Epub 2011 Oct 27].
11. Bell T.H., Berta D., Ralley F., et al. Factors affecting perioperative blood loss and transfusion rates in primary total joint arthroplasty: a prospective analysis of 1642 patients. Can J Surg 2009, 52(4):295.
12. Roth T.M., Gustilo-Ashby T., Barber M.D., et al. Effects of race and clinical factors on short-term outcomes of abdominal myomectomy. Obstet Gynecol 2003, 101(5 Pt 1):881.
13. Segal J.B., Guallar E., Powe N.R. Autologous blood transfusion in the United States: clinical and nonclinical determinants of use. Transfusion 2001, 41(12):1539.
14. Rogers M.A., Blumberg N., Heal J.M., et al. Utilization of blood transfusion among older adults in the United States. Transfusion 2011, 51(4):710.
15. Pedersen A.B., Mehnert F., Overgaard S., et al. Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study. BMC Musculoskelet Disord 2009, 10:167.
16. Jans O., Kehlet H., Johansson P.I. Transfusion-related mortality after primary hip arthroplasty - an analysis of mechanisms and confounders. Vox Sang 2012, 103(4):301.
17. Bierbaum B.E., Callaghan J.J., Galante J.O., et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999, 81(1):2.
18. Husted H., Lunn T.H., Troelsen A., et al. Why still in hospital after fast-track hip and knee arthroplasty?. Acta Orthop 2011, 82(6):679. [Epub 2011 Nov 9].
19. Shander A., Hofmann A., Ozawa S., et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010, 50(4):753. Epub 2009 Dec 9.
20. Conlon N.P., Bale E.P., Herbison G.P., et al. Postoperative anemia and quality of life after primary hip arthroplasty in patients over 65years old. Anesth Analg 2008, 106(4):1056.
21. Carson J.L., Duff A., Poses R.M., et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996, 348(9034):1055.
22. Spence R.K. Anemia in the patient undergoing surgery and the transfusion decision. A review. Clin Orthop Relat Res 1998, (357):19. Review.
23. Rosencher N., Kerkkamp H.E., Macheras G., et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003, 43(4):459.
24. Boralessa H., Cockburn H., Casbard A., et al. Review of transfusion practice in orthopaedic surgery. Curr Orthop 2004, 18:126.
25. Joy P.J., Bennet S.J. The appropriateness of blood transfusion following primary total hip replacement. Ann R Coll Surg Engl 2012, 94(3):201.
26. Jans Ø., Kehlet H., Hussain Z., et al. Transfusion practice in hip arthroplasty-a nationwide study. Vox Sang 2011, 100(4):374.
27. Carson J.L., Carless P.A., Hebert P.C. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012, 4. CD002042, Review.